3rd EAS Pediatric Familial Hypercholesterolemia symposium

Programme
09.00 - 09.05	Welcome and Introduction
Symposium Pediatric FH Worldwide (Joep Defesche and Meeike D Kusters)
09.05 - 09.25	The Italian Experience – Ornella Guardamagna
09.25 - 09.45	The Japanese Experience – Mariko Harada-Shiba
09.45-10.05	The (homozygous) Israeli Experience – Eldad Dann
10.05-10.30	Which FH pat is at highest CVD risk? – Amy Peterson
10.30-10.50	The need to detect early – Bert Wiegman
10.50-11.10	Coffee break
11.10-11.30	Results International Children’s registry – Uma Ramaswami
11.30-11.50	Clinical Decision Support tool: IAS Register – Michal Vrablik
11.50-12.10	Update treatment pediatric heterozygous FH – Ilse Luirink
12.10-12.30	Drug treatment in homozygous FH – Jeanine Roeters van Lennep
12.30-13.30	Lunch
Miscellaneous (Barbara Hutten and Euridiki Drogari)
13.30-13.50	High lipoprotein (a) in childhood and its consequence – Florian Kronenberg
13.50-14.10	Update on LAL-deficiency and other FH phenocopies – Mafalda Bourbon
14.10-14.30	Nutrition in preventing high cholesterol – Kirsten Holven
14.30-14.45	Tea break
Symposium Universal Cholesterol Screening (Gerald Watts and Tomas Freiberger)
14.45-15.05	Universal screening 1-2yr olds (UK) (vaccination) – Steve Humphries
15.05-15.25	Universal screening 5yr olds (Slov) (yrs of experience) – Urh Groselj
15.25-15.45	Universal screening in 9-11 yr olds (USA) – Sam Gidding
15.45-16.30	Panel discussion Universal cholesterol screening